Cure My Disease
Don't miss your cure!
Clinical trials sponsored by National Cancer Institute, Naples, explained in plain language.
This early-phase trial tests a cancer vaccine (IMA970A) combined with an immunotherapy drug (durvalumab) in 10 patients with early- to intermediate-stage liver cancer who have already received standard treatments. The goal is to see if the combination is safe and can help reduce …
Phase: PHASE1 • Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC